Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study

The Interleukin-1 Balance During Encephalitis Is Associated With Clinical Severity, Blood-Brain Barrier Permeability, Neuroimaging Changes, and Disease Outcome

(2015) Benedict Daniel Michael et al.   JOURNAL OF INFECTIOUS DISEASES

Elevated IL-6 and TNF-α Levels in Cerebrospinal Fluid of Subarachnoid Hemorrhage Patients

(2015) Wei Wu et al.   MOLECULAR NEUROBIOLOGY

Elevated Baseline C-Reactive Protein as a Predictor of Outcome After Aneurysmal Subarachnoid Hemorrhage

(2015) Carole L. Turner et al.   NEUROSURGERY

Interleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms

(2015) Hung-Wen Kao et al.   PLoS One

Recombinant Human Interleukin-1 Receptor Antagonist in Severe Traumatic Brain Injury: A Phase II Randomized Control Trial

(2014) Adel Helmy et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial

(2014) Navneet Singh et al.   Journal of Neuroinflammation

Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial

(2014) Peter J Kirkpatrick et al.   LANCET NEUROLOGY

Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology

(2012) A. D. Greenhalgh et al.   Disease Models & Mechanisms

Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage

(2012) Catherine J McMahon et al.   Journal of NeuroInterventional Surgery

Early platelet activation, inflammation and acute brain injury after a subarachnoid hemorrhage: a pilot study

(2012) J. A. FRONTERA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage

(2011) Gabriel JE Rinkel et al.   LANCET NEUROLOGY

Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis

(2011) Brooke E Gilliam et al.   Pediatric Rheumatology

Intravenous Anakinra can Achieve Experimentally Effective Concentrations in the Central Nervous System within a Therapeutic Time Window: Results of a Dose-Ranging Study

(2010) James Galea et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Relevance of Cerebral Interleukin-6 After Aneurysmal Subarachnoid Hemorrhage

(2010) Asita Sarrafzadeh et al.   Neurocritical Care

Neutralization of Interleukin-1β Reduces Vasospasm and Alters Cerebral Blood Vessel Density Following Experimental Subarachnoid Hemorrhage in Rats

(2009) Halina Jedrzejowska-Szypulka et al.   CURRENT NEUROVASCULAR RESEARCH

Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial

(2009) Ming-Yuan Tseng et al.   JOURNAL OF NEUROSURGERY

Systematic Review and Stratified Meta-analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke

(2009) Victoria Banwell et al.   Journal of Stroke & Cerebrovascular Diseases

Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review

(2009) Valery L Feigin et al.   LANCET NEUROLOGY

EFFECT OF A FREE RADICAL SCAVENGER, EDARAVONE, IN THE TREATMENT OF PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE

(2009) Akira Munakata et al.   NEUROSURGERY

Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage

(2007) Ivelina Gueorguieva et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY